Pharma and Biotech (DLS30)

 0.00
   
  • 52 Week High: NULL
  • 52 Week Low: 0.00

Latest ShareCast News

PureTech Health contract revenues surge, cuts costs as portfolio strategy evolves

By Iain Gilbert

Date: Thursday 28 Aug 2025

(Sharecast News) - Biotherapeutics firm Puretech Health said on Thursday that it had made "meaningful progress" across its portfolio in the first half of 2025, with contract revenues soaring throughout the period.

Faron narrows first-half losses as it advances its lead asset

By Josh White

Date: Wednesday 27 Aug 2025

(Sharecast News) - Faron Pharmaceuticals reported a series of first-half clinical and financial milestones on Wednesday, as it advanced its lead asset, bexmarilimab, through late-stage development in high-risk myelodysplastic syndromes (HR-MDS).

ValiRx launches prostate cancer subsidiary Blue Ribbon Bio

By Josh White

Date: Tuesday 26 Aug 2025

(Sharecast News) - ValiRx announced a new wholly owned subsidiary Blue Ribbon Bio on Tuesday, to consolidate its prostate cancer assets and accelerate development of its Val201 peptide therapy.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 0.00
Closing Price Change 0.00
% Change 0.00 %
--25 Close 0.00

Top Risers

Price Change
HEMO 345.00p +84.0%
APTA 1.00p +20.5%
NFX 0.088p +17.3%
GENF 0.75p +15.4%
IMM 1.80p +13.1%
GUN 0.12p +9.5%
AVCT 55.00p +8.9%
TCF 0.24p +6.7%
VAL 0.58p +4.5%
SCLP 10.50p +4.5%

Top Fallers

Price Change
FARN 197.50p -11.2%
OVB 1.05p -9.1%
AGY 8.00p -8.0%
BXP 46.50p -7.9%
SVNS 0.28p -6.8%
ONT 187.20p -6.3%
OBI 15.50p -6.1%
PRTC 126.60p -5.5%
FUM 9.00p -5.3%
PRM 2.85p -5.0%

Top of Page